Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression...
Leadership
Amit Etkin M.D., Ph.D.Founder
Founder, Chairman of the Board, CEO & President
Nicholas C. Smith
CFO & Chief Business Officer
Michael C. Hanley M.B.A.
Chief Operating Officer
Dan Segal B.Sc. (Hons), BCom, CA, MScFounder
Co-Founder & Strategic Advisor
Erin R. McQuade J.D.
General Counsel, Chief Administrative Officer & Corporate Secretary
